Repare Therapeutics Inc. financial data

Symbol
RPTX on Nasdaq
Location
7171 Frederick Banting, Suite 270, Building 2, Saint Laurent, Quebec, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 741 % +5.62%
Debt-to-equity 15.2 % -8.41%
Return On Equity -57.6 % -40.8%
Return On Assets -50 % -42.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43M shares +1.12%
Common Stock, Shares, Outstanding 43M shares +1.12%
Entity Public Float 129M USD -66.3%
Common Stock, Value, Issued 490M USD +0.78%
Weighted Average Number of Shares Outstanding, Basic 43M shares +1.21%
Weighted Average Number of Shares Outstanding, Diluted 43.1M shares +1.41%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 66.6M USD -47.5%
General and Administrative Expense 24.5M USD -23.4%
Operating Income (Loss) -78.5M USD +16.3%
Nonoperating Income (Expense) 7.05M USD -37.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -71.4M USD +13.3%
Income Tax Expense (Benefit) 763K USD -53.2%
Net Income (Loss) Attributable to Parent -72.2M USD +14.1%
Earnings Per Share, Basic -1 USD/shares +14.6%
Earnings Per Share, Diluted -1 USD/shares +15.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 72.8M USD -9.58%
Marketable Securities, Current 39.8M USD -59.8%
Assets, Current 124M USD -37.9%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 600K USD +235%
Assets 127M USD -38.6%
Accounts Payable, Current 1.33M USD -87.5%
Employee-related Liabilities, Current 2.35M USD -52.9%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 11.6M USD -62.6%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 11.6M USD -63%
Accumulated Other Comprehensive Income (Loss), Net of Tax 14K USD -90%
Retained Earnings (Accumulated Deficit) -461M USD -18.6%
Stockholders' Equity Attributable to Parent 115M USD -34.2%
Liabilities and Equity 127M USD -38.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.1M USD -344%
Net Cash Provided by (Used in) Financing Activities 79K USD -78.9%
Net Cash Provided by (Used in) Investing Activities 28.8M USD
Common Stock, Shares, Issued 43M shares +1.12%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -262K USD +96.7%
Deferred Tax Assets, Valuation Allowance 140M USD +25.3%
Deferred Tax Assets, Gross 140M USD +25.3%
Operating Lease, Liability 1.93M USD -43.3%
Depreciation 1.19M USD +137%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -72.3M USD +13.5%
Lessee, Operating Lease, Liability, to be Paid 2M USD -43%
Property, Plant and Equipment, Gross 11.5M USD -0.18%
Operating Lease, Liability, Current 342K USD -84.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 88K USD -91.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.91M USD -23.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +39%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 68K USD -33.3%
Deferred Tax Assets, Operating Loss Carryforwards 92.7M USD +32.6%
Preferred Stock, Shares Issued 0 shares
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 590K USD -3.75%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 12.3M USD -49.9%